DEXMEDETOMIDINE in NORMAL VAGINAL DELIVERY

• Status: Recruiting
• Trial end date: 2023-07-05
• Target enrollment: 0
• Participant gender: Female

Summary

compare the effect of intravenous and epidural dexmetomidine as an adjuvant to local anesthetics in epidural labor analgesia in normal labor

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Menoufia University
• Treatments: Bupivacaine; Dexmedetomidine

Criteria

Inclusion Criteria:

• Full term (≥ 37 weeks) healthy primigravida parturients ASA2

• with single fetus scheduled for vaginal delivery

• with cephalic presentation

• requesting labor analgesia.

Exclusion Criteria:

• Allergy to dexmetomidine.(based on previous history)

• Cardiac conduction abnormalities.(all degrees of heart block , tachyarrythmias)

• Twins.

• Malpresentation.

• Preeclampsia or gestational hypertension

• Uncontrolled diabetes HBA1c ≥ 6.5%

• Uncontrolled renal failure

• Uncontrolled liver disease

• Bleeding tendency or coagulopathy.

• Contraindication or patient refusal to epidural block.

• Body mass index ≥ 35.